688621.SS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 09:00):

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China...

Stats
Dagens volum	1.39M
Gjennomsnittsvolum	1.10M
Markedsverdi	6.31B
EPS	CNY0 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	31.84
ATR14	CNY0.0290 (0.05%)

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: 0.51 (weak)

Signal:(31.651) Neutral

Beijing Sun-Novo Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Beijing Sun-Novo Korrelasjon - Valuta/Råvare

-0.62
( weak negative )

-0.67
( moderate negative )

0.00
( neutral )

-0.53
( weak negative )

-0.57
( weak negative )

0.35
( neutral )

Beijing Sun-Novo Økonomi

Annual	2023
Omsetning:	CNY932.12M
Bruttogevinst:	CNY528.35M (56.68 %)
EPS:	CNY1.650

FY	2023
Omsetning:	CNY932.12M
Bruttogevinst:	CNY528.35M (56.68 %)
EPS:	CNY1.650

FY	2022
Omsetning:	CNY676.61M
Bruttogevinst:	CNY375.46M (55.49 %)
EPS:	CNY1.390

FY	2021
Omsetning:	CNY493.65M
Bruttogevinst:	CNY263.68M (53.41 %)
EPS:	CNY1.764

Financial Reports:

No articles found.

Beijing Sun-Novo

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.